Difference between MV-NMV gene expression means is shown for each gene in the late period (from day 9 in the course of the disease).Click here for file(63K, doc)Additional file 10:Table S3: Gene expression levels by intracellular signaling pathway (CD28 signaling in T helper cells). Difference between MV-NMV gene expression means is shown for each gene Belinostat msds in the late period (from day 9 in the course of the disease).Click here for file(62K, doc)Additional file 11:Table S4: Gene expression levels by intracellular signaling pathway (dendritic cell maturation). Difference between MV-NMV gene expression means is shown for each gene in the late period (from day 9 in the course of the disease).Click here for file(72K, doc)Additional file 12:Table S5: Gene expression levels by intracellular signaling pathway (T helper cell differentiation).
Difference between MV-NMV gene expression means is shown for each gene in the late period (from day 9 in the course of the disease).Click here for file(73K, doc)Additional file 13:Table S6: Gene expression levels by intracellular signaling pathway (protein ubiquitination pathway). Difference between MV-NMV gene expression means is shown for each gene in the late period (from day 9 in the course of the disease).Click here for file(93K, doc)Additional file 14:Table S7: Gene expression levels by intracellular signaling pathway (apoptosis signaling). Difference between MV-NMV gene expression means is shown for each gene in the late period (from day 9 in the course of the disease).
Click here for file(56K, doc)Additional file 15:Table S8: Gene expression levels by intracellular signaling pathway (B cell receptor signaling). Difference between MV-NMV gene expression means is shown for each gene in the late period (from day 9 in the course of the disease).Click here for file(66K, doc)Additional file 16:Table S9: Gene expression levels by intracellular signaling pathway (IL-6, IL-10 signaling). Difference between MV-NMV gene expression means is shown for each gene in the late period (from day 9 in the course of the disease).Click here for file(67K, doc)Additional file 17:Table S10: Comparison of immune mediator levels, early period (before day 9 in the course of the disease). Data are represented as median (interquartile range) of the ratios MV/(control median) and NMV/(control median). *Significant differences at the level P < 0.
05. (n.s.), nonsignificant differences. IFN-��, IFN-�� (IL-28) and IL-23 were undetectable in the vast majority of the patients in both groups along the course of the disease.Click here for file(55K, doc)Additional Anacetrapib file 18:Table S11: Comparison of immune mediator levels, late period (from day 9 in the course of the disease). Data are represented as median (interquartile range) of the ratios MV/(control median) and NMV/(control median). *P < 0.05. n.s., nonsignificant differences.
No related posts.